Digital health—Germany—Q&A guide

The following Life Sciences practice note provides comprehensive and up to date legal information covering:

  • Digital health—Germany—Q&A guide
  • 1. Who are the key players active in your local digital health market and what are the most prominent areas of innovation?
  • 2. How would you describe the investment climate for digital health technologies in your jurisdiction, including any noteworthy challenges?
  • 3. What are the most notable recent deals in the digital health sector in your jurisdiction?
  • 4. What due diligence issues should investors address before acquiring a stake in digital health ventures?
  • 5. What financing structures are commonly used by digital health ventures in your jurisdiction? Are there any notable government financing or other support initiatives to promote development of the digital health space?
  • 6. What principal legislation governs the digital health sector in your jurisdiction?
  • 7. Which notable regulatory and enforcement bodies have jurisdiction over the digital health sector?
  • 8. What licensing and authorisation requirements and procedures apply to the provision of digital health products and services in your jurisdiction?
  • 9. Is there any notable ‘soft’ law or guidance governing digital health?
  • More...

Digital health—Germany—Q&A guide

This Practice Note contains a jurisdiction-specific Q&A guide to digital health in Germany published as part of the Lexology Getting the Deal Through series by Law Business Research (published: June 2021).

Authors: Taylor Wessing—Dr. Nora E. Wessendorf; Thanos Rammos; Tim Jonathan Schwarz; Daniel Tietjen; Stephan Doom; Karolina Lange-Kulmann; Angela Knierim

1. Who are the key players active in your local digital health market and what are the most prominent areas of innovation?

A variety of players are active in the German digital health market. They range from innovative, often venture-capital-backed start-ups focusing on rather specific niches, such as services geared towards a single condition or specific use case, to larger players such as global pharmaceutical and med-tech companies. The latter have recognised that digital health solutions can be very useful in accelerating product development, for example, by enabling digital clinical trials, and in extending the value chain by offering apps to be prescribed alongside regular medication.

Healthcare providers such as hospitals and outpatient chains have shown a high interest in establishing telemedicine platforms and online portals for their patients, which are often promoted by statutory and private health insurance funds. In addition, healthcare providers are working on becoming 'smarter' in general by digitising internal procedures such as clinical documentation and medication management systems and by integrating artificial intelligence in certain diagnostics.

Besides these life sciences and healthcare

Popular documents